The ubiquitin-proteasome system in positive-strand RNA virus infection

Reviews in Medical Virology

Volumn 23, Issue 2, 2013, Pages 85-96

  Choi, Alex Goeun ^a   Wong, Jerry ^a   Marchant, David ^a   Luo, Honglin ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPROTEASE; NONSTRUCTURAL PROTEIN 3; PROTEASOME; PROTEINASE; RNA DIRECTED RNA POLYMERASE; STRUCTURAL PROTEIN; SUMO 1 PROTEIN; SUMO 2 PROTEIN; SUMO 3 PROTEIN; UBIQUITIN; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; HEPATITIS C VIRUS; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; RNA VIRUS; RNA VIRUS INFECTION; SIGNAL TRANSDUCTION; SUMOYLATION; UBIQUITINATION; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS; RNA VIRUS INFECTIONS; RNA VIRUSES; UBIQUITIN; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84874708174     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1725     Document Type: Review

References (100)

1. Van Regenmortel MHV. Virus Taxonomy. Academic Press: San Diego, Calif. 2000.
2. Gao G, Luo H. The ubiquitin-proteasome pathway in viral infections. Canadian Journal of Physiology and Pharmacology 2006; 84(1): 5-14.
3. Luo H, Wong J, Wong B. Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Cardiovascular Research 2010; 85(2): 347-356.
4. Banerjee R, Weidman MK, Echeverri A, Kundu P, Dasgupta A. Regulation of poliovirus 3C protease by the 2C polypeptide. Journal of Virology 2004; 78(17): 9243-9256.
5. Camborde L, Planchais S, Tournier V, Jakubiec A, Drugeon G, Lacassagne E, Pflieger S, Chenon M, Jupin I. The ubiquitin-proteasome system regulates the accumulation of turnip yellow mosaic virus RNA-dependent RNA polymerase during viral infection. The Plant Cell 2010; 22(9): 3142-3152.
6. Kerkvliet J, Papke L, Rodriguez M. Antiviral effects of a transgenic RNA-dependent RNA polymerase. Journal of Virology 2011; 85(1): 621-625.
7. Randow F, Lehner PJ. Viral avoidance and exploitation of the ubiquitin system. Nature Cell Biology 2009; 11(5): 527-534.
8. Viswanathan K, Fruh K, Defilippis V. Viral hijacking of the host ubiquitin system to evade interferon responses. Current Opinion in Microbiology 2010; 13(4): 517-523.
9. Rechsteiner M. Natural substrates of the ubiquitin proteolytic pathway. Cell 1991; 66(4): 615-618.
10. Welchman RL, Gordon C, Mayer RJ. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nature Reviews Molecular Cell Biology 2005; 6(8): 599-609.
11. Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 2002; 82(2): 373-428.
12. Pickart CM. Ubiquitin in chains. Trends in Biochemical Sciences 2000; 25(11): 544-548.
13. Pickart CM. Ubiquitin enters the new millennium. Molecular Cell 2001; 8(3): 499-504.
14. Amerik AY, Hochstrasser M. Mechanism and function of deubiquitinating enzymes. Biochimica et Biophysica Acta 2004; 1695(1-3): 189-207.
15. Mao I, Liu J, Li X, Luo H. REGgamma, a proteasome activator and beyond? Cellular and Molecular Life Sciences 2008; 65(24): 3971-3980.
16. Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, Haas W, Gygi SP, Ploegh HL, Bernards R, D'andrea AD. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nature Cell Biology 2006; 8(4): 339-347.
17. Sun L, Chen ZJ. The novel functions of ubiquitination in signaling. Current Opinion in Cell Biology 2004; 16(2): 119-126.
18. Boggio R, Chiocca S. Viruses and sumoylation: recent highlights. Current Opinion in Microbiology 2006; 9(4): 430-436.
19. Hericourt F, Blanc S, Redeker V, Jupin I. Evidence for phosphorylation and ubiquitinylation of the turnip yellow mosaic virus RNA-dependent RNA polymerase domain expressed in a baculovirus-insect cell system. Biochemical Journal 2000; 349(Pt 2): 417-425.
20. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nature Reviews Molecular Cell Biology 2007; 8(12): 947-956.
21. Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes & Development 2004; 18(17): 2046-2059.
22. Verger A, Perdomo J, Crossley M. Modification with SUMO. A role in transcriptional regulation. EMBO Reports 2003; 4(2): 137-142.
23. Hilgarth RS, Murphy LA, Skaggs HS, Wilkerson DC, Xing H, Sarge KD. Regulation and function of SUMO modification. Journal of Biological Chemistry 2004; 279(52): 53899-53902.
24. Skaug B, Chen ZJ. Emerging role of ISG15 in antiviral immunity. Cell 2010; 143(2): 187-190.
25. Zhang D, Zhang DE. Interferon-stimulated gene 15 and the protein ISGylation system. Journal of Interferon and Cytokine Research 2011; 31(1): 119-130.
26. Dai J, Pan W, Wang P. ISG15 facilitates cellular antiviral response to dengue and West Nile virus infection in vitro. Virology Journal 2011; 8: 468.
27. Giannakopoulos NV, Arutyunova E, Lai C, Lenschow DJ, Haas AL, Virgin HW. ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus. Journal of Virology 2009; 83(4): 1602-1610.
28. Hsiao NW, Chen JW, Yang TC, Orloff GM, Wu YY, Lai CH, Lan YC, Lin CW. ISG15 over-expression inhibits replication of the Japanese encephalitis virus in human medulloblastoma cells. Antiviral Research 2010; 85(3): 504-511.
29. Broering R, Zhang X, Kottilil S, Trippler M, Jiang M, Lu M, Gerken G, Schlaak JF. The interferon stimulated gene 15 functions as a proviral factor for the hepatitis C virus and as a regulator of the IFN response. Gut 2010; 59(8): 1111-1119.
30. Chen L, Li S, Mcgilvray I. The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in hepatitis C virus infection and resistance to interferon therapy. The International Journal of Biochemistry & Cell Biology 2011; 43(10): 1427-1431.
31. Chen L, Sun J, Meng L, Heathcote J, Edwards AM, Mcgilvray ID. ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment. Journal of General Virology 2010; 91(Pt 2): 382-388.
32. Ahlquist P. RNA-dependent RNA polymerases, viruses, and RNA silencing. Science 2002; 296(5571): 1270-1273.
33. Jaag HM, Stork J, Nagy PD. Host transcription factor Rpb11p affects tombusvirus replication and recombination via regulating the accumulation of viral replication proteins. Virology 2007; 368(2): 388-404.
34. Pantaleo V, Rubino L, Russo M. The p36 and p95 replicase proteins of Carnation Italian ringspot virus cooperate in stabilizing defective interfering RNA. Journal of General Virology 2004; 85(Pt 8): 2429-2433.
35. Schwartz M, Chen J, Lee WM, Janda M, Ahlquist P. Alternate, virus-induced membrane rearrangements support positive-strand RNA virus genome replication. Proceedings of the National Academy of Sciences of the United States of America 2004; 101(31): 11263-11268.
36. Kerkvliet J, Zoecklein L, Papke L, Denic A, Bieber AJ, Pease LR, David CS, Rodriguez M. Transgenic expression of the 3D polymerase inhibits Theiler's virus infection and demyelination. Journal of Virology 2009; 83(23): 12279-12289.
37. Kerkvliet J, Edukulla R, Rodriguez M. Novel roles of the picornaviral 3D polymerase in viral pathogenesis. Advances in Virology 2010; 2010: 368068.
38. De Groot RJ, Rumenapf T, Kuhn RJ, Strauss EG, Strauss JH. Sindbis virus RNA polymerase is degraded by the N-end rule pathway. Proceedings of the National Academy of Sciences of the United States of America 1991; 88(20): 8967-8971.
39. Gao L, Tu H, Shi ST, Lee KJ, Asanaka M, Hwang SB, Lai MM. Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. Journal of Virology 2003; 77(7): 4149-4159.
40. Losick VP, Schlax PE, Emmons RA, Lawson TG. Signals in hepatitis A virus P3 region proteins recognized by the ubiquitin-mediated proteolytic system. Virology 2003; 309(2): 306-319.
41. Bachmair A, Finley D, Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science 1986; 234(4773): 179-186.
42. Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986; 234(4774): 364-368.
43. Updike WS, Tesar M, Ehrenfeld E. Detection of hepatitis A virus proteins in infected BS-C-1 cells. Virology 1991; 185(1): 411-418.
44. Si X, Gao G, Wong J, Wang Y, Zhang J, Luo H. Ubiquitination is required for effective replication of coxsackievirus B3. PloS One 2008; 3(7): e2585.
45. Blair WS, Semler BL. Self-cleaving proteases. Current Opinion in Cell Biology 1991; 3(6): 1039-1045.
46. Lloyd RE. Translational control by viral proteinases. Virus Research 2006; 119(1): 76-88.
47. Gauss-Muller V, Jurgensen D, Deutzmann R. Autoproteolytic cleavage of recombinant 3C proteinase of hepatitis A virus. Virology 1991; 182(2): 861-864.
48. Gladding RL, Haas AL, Gronros DL, Lawson TG. Evaluation of the susceptibility of the 3C proteases of hepatitis A virus and poliovirus to degradation by the ubiquitin-mediated proteolytic system. Biochemical and Biophysical Research Communication 1997; 238(1): 119-125.
49. Lawson TG, Smith LL, Palmenberg AC, Thach RE. Inducible expression of encephalomyocarditis virus 3C protease activity in stably transformed mouse cell lines. Journal of Virology 1989; 63(12): 5013-5022.
50. Oberst MD, Gollan TJ, Gupta M, Peura SR, Zydlewski JD, Sudarsanan P, Lawson TG. The encephalomyocarditis virus 3C protease is rapidly degraded by an ATP-dependent proteolytic system in reticulocyte lysate. Virology 1993; 193(1): 28-40.
51. Lawson TG, Gronros DL, Evans PE, Bastien MC, Michalewich KM, Clark JK, Edmonds JH, Graber KH, Werner JA, Lurvey BA, Cate JM. Identification and characterization of a protein destruction signal in the encephalomyocarditis virus 3C protease. Journal of Biological Chemistry 1999; 274(14): 9904-9980.
52. Lawson TG, Gronros DL, Werner JA, Wey AC, Digeorge AM, Lockhart JL, Wilson JW, Wintrode PL. The encephalomyocarditis virus 3C protease is a substrate for the ubiquitin-mediated proteolytic system. Journal of Biological Chemistry 1994; 269(45): 28429-28435.
53. Lawson TG, Sweep ME, Schlax PE, Bohnsack RN, Haas AL. Kinetic analysis of the conjugation of ubiquitin to picornavirus 3C proteases catalyzed by the mammalian ubiquitin-protein ligase E3alpha. Journal of Biological Chemistry 2001; 276(43): 39629-39637.
54. Chen SC, Chang LY, Wang YW, Chen YC, Weng KF, Shih SR, Shih HM. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis. Journal of Biological Chemistry 2011; 286(36): 31373-31384.
55. Barco A, Feduchi E, Carrasco L. Poliovirus protease 3C(pro) kills cells by apoptosis. Virology 2000; 266(2): 352-360.
56. Chau DH, Yuan J, Zhang H, Cheung P, Lim T, Liu Z, Sall A, Yang D. Coxsackievirus B3 proteases 2A and 3C induce apoptotic cell death through mitochondrial injury and cleavage of eIF4GI but not DAP5/p97/NAT1. Apoptosis 2007; 12(3): 513-524.
57. Franck N, Le Seyec J, Guguen-Guillouzo C, Erdtmann L. Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome. Journal of Virology 2005; 79(5): 2700-2708.
58. Welbourn S, Green R, Gamache I, Dandache S, Lohmann V, Bartenschlager R, Meerovitch K, Pause A. Hepatitis C virus NS2/3 processing is required for NS3 stability and viral RNA replication. Journal of Biological Chemistry 2005; 280(33): 29604-29611.
59. Welbourn S, Jirasko V, Breton V, Reiss S, Penin F, Bartenschlager R, Pause A. Investigation of a role for lysine residues in non-structural proteins 2 and 2/3 of the hepatitis C virus for their degradation and virus assembly. Journal of General Virology 2009; 90(Pt 5): 1071-1080.
60. Aschauer B, Werner G, Mccray J, Rosenwirth B, Bachmayer H. Biologically active protease 3C of human rhinovirus 1A is expressed from a cloned cDNA segment in Escherichia coli. Virology 1991; 184(2): 587-594.
61. Thomas AA, Voorma HO, Boeye A. Relationship between synthesis and cleavage of poliovirus-specific proteins. Journal of Virology 1983; 48(1): 309-313.
62. Tholstrup J, Oddershede LB, Sorensen MA. mRNA pseudoknot structures can act as ribosomal roadblocks. Nucleic Acids Research 2012; 40(1): 303-313.
63. Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. Journal of Virology 2005; 79(24): 15189-15198.
64. Chen Z, Wang Y, Ratia K, Mesecar AD, Wilkinson KD, Baker SC. Proteolytic processing and deubiquitinating activity of papain-like proteases of human coronavirus NL63. Journal of Virology 2007; 81(11): 6007-6018.
65. Clementz MA, Chen Z, Banach BS, Wang Y, Sun L, Ratia K, Baez-Santos YM, Wang J, Takayama J, Ghosh AK, Li K, Mesecar AD, Baker SC. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. Journal of Virology 2010; 84(9): 4619-4629.
66. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. Journal of Virology 2005; 79(24): 15199-15208.
67. Ratia K, Pegan S, Takayama J, Sleeman K, Coughlin M, Baliji S, Chaudhuri R, Fu W, Prabhakar BS, Johnson ME, Baker SC, Ghosh AK, Mesecar AD. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proceedings of the National Academy of Sciences of the United States of America 2008; 105(42): 16119-16124.
68. Ratia K, Saikatendu KS, Santarsiero BD, Barretto N, Baker SC, Stevens RC, Mesecar AD. Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme. Proceedings of the National Academy of Sciences of the United States of America 2006; 103(15): 5717-5722.
69. Karpe YA, Lole KS. Deubiquitination activity associated with hepatitis E virus putative papain-like cysteine protease. Journal of General Virology 2011; 92(Pt 9): 2088-2092.
70. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, Chen Z, Xiao S. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. Journal of Virology 2011; 85(8): 3758-3766.
71. Bell YC, Semler BL, Ehrenfeld E. Requirements for RNA replication of a poliovirus replicon by coxsackievirus B3 RNA polymerase. Journal of Virology 1999; 73(11): 9413-9421.
72. Khaliq S, Jahan S, Pervaiz A. Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production. Emerging Infectious Diseases 2011; 11(3): 543-556.
73. Watashi K, Shimotohno K. The roles of hepatitis C virus proteins in modulation of cellular functions: a novel action mechanism of the HCV core protein on gene regulation by nuclear hormone receptors. Cancer Science 2003; 94(11): 937-943.
74. Miyamoto H, Moriishi K, Moriya K, Murata S, Tanaka K, Suzuki T, Miyamura T, Koike K, Matsuura Y. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. Journal of Virology 2007; 81(4): 1727-1735.
75. Moriishi K, Mochizuki R, Moriya K, Miyamoto H, Mori Y, Abe T, Murata S, Tanaka K, Miyamura T, Suzuki T, Koike K, Matsuura Y. Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2007; 104(5): 1661-1666.
76. Moriishi K, Okabayashi T, Nakai K, Moriya K, Koike K, Murata S, Chiba T, Tanaka K, Suzuki R, Suzuki T, Miyamura T, Matsuura Y. Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein. Journal of Virology 2003; 77(19): 10237-10249.
77. Moriishi K, Shoji I, Mori Y, Suzuki R, Suzuki T, Kataoka C, Matsuura Y. Involvement of PA28gamma in the propagation of hepatitis C virus. Hepatology 2010; 52(2): 411-420.
78. Shirakura M, Murakami K, Ichimura T, Suzuki R, Shimoji T, Fukuda K, Abe K, Sato S, Fukasawa M, Yamakawa Y, Nishijima M, Moriishi K, Matsuura Y, Wakita T, Suzuki T, Howley PM, Miyamura T, Shoji I. E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. Journal of Virology 2007; 81(3): 1174-1185.
79. Suzuki R, Moriishi K, Fukuda K, Shirakura M, Ishii K, Shoji I, Wakita T, Miyamura T, Matsuura Y, Suzuki T. Proteasomal turnover of hepatitis C virus core protein is regulated by two distinct mechanisms: a ubiquitin-dependent mechanism and a ubiquitin-independent but PA28gamma-dependent mechanism. Journal of Virology 2009; 83(5): 2389-2392.
80. Suzuki R, Tamura K, Li J, Ishii K, Matsuura Y, Miyamura T, Suzuki T. Ubiquitin-mediated degradation of hepatitis C virus core protein is regulated by processing at its carboxyl terminus. Virology 2001; 280(2): 301-309.
81. Xu Z, Choi J, Lu W, Ou JH. Hepatitis C virus f protein is a short-lived protein associated with the endoplasmic reticulum. Journal of Virology 2003; 77(2): 1578-1583.
82. Yuksek K, Chen WL, Chien D, Ou JH. Ubiquitin-independent degradation of hepatitis C virus F protein. Journal of Virology 2009; 83(2): 612-621.
83. Fiorucci M, Boulant S, Fournillier A, Abraham JD, Lavergne JP, Paranhos-Baccala G, Inchauspe G, Bain C. Expression of the alternative reading frame protein of Hepatitis C virus induces cytokines involved in hepatic injuries. Journal of General Virology 2007; 88(Pt 4): 1149-1162.
84. Wu WB, Shao SW, Zhao LJ, Luan J, Cao J, Gao J, Zhu SY, Qi ZT. Hepatitis C virus F protein up-regulates c-myc and down-regulates p53 in human hepatoma HepG2 cells. Intervirology 2007; 50(5): 341-346.
85. Roussel J, Pillez A, Montpellier C, Duverlie G, Cahour A, Dubuisson J, Wychowski C. Characterization of the expression of the hepatitis C virus F protein. Journal of General Virology 2003; 84(Pt 7): 1751-1759.
86. Ko A, Lee EW, Yeh JY, Yang MR, Oh W, Moon JS, Song J. MKRN1 induces degradation of West Nile virus capsid protein by functioning as an E3 ligase. Journal of Virology 2010; 84(1): 426-436.
87. Oh W, Yang MR, Lee EW, Park KM, Pyo S, Yang JS, Lee HW, Song J. Jab1 mediates cytoplasmic localization and degradation of West Nile virus capsid protein. Journal of Biological Chemistry 2006; 281(40): 30166-30174.
88. Yang JS, Ramanathan MP, Muthumani K, Choo AY, Jin SH, Yu QC, Hwang DS, Choo DK, Lee MD, Dang K, Tang W, Kim JJ, Weiner DB. Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway. Emerging Infectious Diseases 2002; 8(12): 1379-1384.
89. Yang MR, Lee SR, Oh W, Lee EW, Yeh JY, Nah JJ, Joo YS, Shin J, Lee HW, Pyo S, Song J. West Nile virus capsid protein induces p53-mediated apoptosis via the sequestration of HDM2 to the nucleolus. Cellular Microbiology 2008; 10(1): 165-176.
90. Alvarez E, Dediego ML, Nieto-Torres JL, Jimenez-Guardeno JM, Marcos-Villar L, Enjuanes L. The envelope protein of severe acute respiratory syndrome coronavirus interacts with the non-structural protein 3 and is ubiquitinated. Virology 2010; 402(2): 281-291.
91. Dunigan DD, Dietzgen RG, Schoelz JE, Zaitlin M. Tobacco mosaic virus particles contain ubiquitinated coat protein subunits. Virology 1988; 165(1): 310-312.
92. Fan Z, Zhuo Y, Tan X, Zhou Z, Yuan J, Qiang B, Yan J, Peng X, Gao GF. SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. Journal of Medical Virology 2006; 78(11): 1365-1373.
93. Li FQ, Xiao H, Tam JP, Liu DX. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus. FEBS Letters 2005; 579(11): 2387-2396.
94. Li Q, Xiao H, Tam JP, Liu DX. Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus by interaction with Ubc9. Advances in Experimental Medicine and Biology 2006; 581: 121-126.
95. Gladue DP, Holinka LG, Fernandez-Sainz IJ, Prarat MV, O'donell V, Vepkhvadze N, Lu Z, Rogers K, Risatti GR, Borca MV. Effects of the interactions of classical swine fever virus Core protein with proteins of the SUMOylation pathway on virulence in swine. Virology 2010; 407(1): 129-136.
96. Chiu MW, Shih HM, Yang TH, Yang YL. The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). Journal of Biomedical Science 2007; 14(3): 429-444.
97. Watanabe Y, Emori Y, Ooshika I, Meshi T, Ohno T, Okada Y. Synthesis of TMV-specific RNAs and proteins at the early stage of infection in tobacco protoplasts: transient expression of the 30K protein and its mRNA. Virology 1984; 133(1): 18-24.
98. Reichel C, Beachy RN. Degradation of tobacco mosaic virus movement protein by the 26S proteasome. Journal of Virology 2000; 74(7): 3330-3337.
99. Li Z, Barajas D, Panavas T, Herbst DA, Nagy PD. Cdc34p ubiquitin-conjugating enzyme is a component of the tombusvirus replicase complex and ubiquitinates p33 replication protein. Journal of Virology 2008; 82(14): 6911-6926.
100. Barajas D, Nagy PD. Ubiquitination of tombusvirus p33 replication protein plays a role in virus replication and binding to the host Vps23p ESCRT protein. Virology 2010; 397(2): 358-368.